Investigational Drug Information for Orvepitant
✉ Email this page to a colleague
What is the drug development status for Orvepitant?
Orvepitant is an investigational drug.
There have been 10 clinical trials for Orvepitant.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2009.
The most common disease conditions in clinical trials are Depressive Disorder, Disease, and Depressive Disorder, Major. The leading clinical trial sponsors are GlaxoSmithKline, Nerre Therapeutics Ltd., and Pharm-Olam International.
Summary for Orvepitant
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 108 |
| WIPO Patent Applications | 68 |
| Japanese Patent Applications | 17 |
| Clinical Trial Progress | Phase 2 (2009-03-01) |
| Vendors | 13 |
Recent Clinical Trials for Orvepitant
| Title | Sponsor | Phase |
|---|---|---|
| Phase 2 Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With IPF | Pharm-Olam International | Phase 2 |
| Phase 2 Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With IPF | Nerre Therapeutics Ltd. | Phase 2 |
| Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects | Nerre Therapeutics Ltd. | Phase 1 |
Clinical Trial Summary for Orvepitant
Top disease conditions for Orvepitant
Top clinical trial sponsors for Orvepitant
US Patents for Orvepitant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
